Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder



Status:Completed
Conditions:Neurology, Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:1 - 18
Updated:7/27/2018
Start Date:January 8, 2016
End Date:June 22, 2017

Use our guide to learn which trials are right for you!

A Multicenter, Open-label, Flexible Dose Study to Assess the Long-term Safety of Pharmaceutical Cannabidiol Oral Solution as an Adjunctive Treatment for Pediatric Subjects With a Treatment-resistant Seizure Disorder Who Complete INS011-14-029 or Part A of INS011-15-054

This is a multicenter, open-label trial to assess the long-term safety and efficacy of
Cannabidiol Oral Solution as adjunctive therapy for pediatric participants with
treatment-resistant seizure disorders, including Lennox-Gastaut syndrome (LGS) or Dravet
syndrome (DS). All participants have rolled over from previous trials: INS011-14-029
(NCT02324673) and INS011-15-054 (NCT02551731).


Inclusion Criteria:

- Completed activities through Day 11 in INS011-14-029 or Part A (Visit 6) INS011-15-054

- Informed consent/assent (as applicable) was voluntarily provided by the participant
and/or parent(s)/caregiver(s) in accordance with applicable laws, regulations, and
local requirements

- Is medically stable with no anticipated changes in chronic medications in the opinion
of the Investigator

- Continues to meet protocol-specified criteria for qualification and contraception,
including treatment-resistant seizure disorder

- In the opinion of the Investigator, the subject and/or parent(s)/caregiver(s) are able
to continue keeping accurate seizure diaries

Exclusion Criteria:

- Inadequate supervision by parent(s)/caregiver(s)

- History or current use of dietary supplements, drugs or over-the counter medications
outside protocol-specified parameters

- Signs, symptoms or history of any condition that, per protocol or in the opinion of
the investigator, might compromise:

1. the safety or well-being of the participant or study staff

2. the safety or well-being of the participant's offspring (such as through
pregnancy or breast-feeding)

3. the analysis of results
We found this trial at
11
sites
3100 SW 62nd Ave
Miami, Florida 33155
(305) 666-6511
Miami Children's Hospital Welcome to Miami Children
?
mi
from
Miami, FL
Click here to add this to my saved trials
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
5841 S Maryland Ave
Chicago, Illinois 60637
(773) 702-1000
University of Chicago Medical Center The University of Chicago Medicine has been at the forefront...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Las Vegas, Nevada 89104
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Memphis, Tennessee 38103
?
mi
from
Memphis, TN
Click here to add this to my saved trials
Pensacola, Florida 32504
?
mi
from
Pensacola, FL
Click here to add this to my saved trials
Portland, Oregon 97239
?
mi
from
Portland, OR
Click here to add this to my saved trials
Riverton, Utah 84096
?
mi
from
Riverton, UT
Click here to add this to my saved trials
505 Parnassus Ave
San Francisco, California 94143
(415) 476-1000
University of California, San Francisco Medical Center UCSF Medical Center is recognized throughout the world...
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Tacoma, Washington 98405
?
mi
from
Tacoma, WA
Click here to add this to my saved trials